About the Retinal Tumors Session
Retinal tumors, though rare, present significant challenges in diagnosis and treatment. These tumors can arise from various cell types within the retina and may be benign or malignant. Early detection is crucial for preserving vision and preventing metastasis. Advancements in imaging technologies such as optical coherence tomography (OCT) and fundus fluorescein angiography (FFA) have enhanced diagnostic accuracy. Treatment options include laser therapy, cryotherapy, radiation, and surgical interventions like enucleation or vitrectomy. Emerging therapies like targeted drug delivery and immunotherapy offer promising avenues for personalized treatment approaches. Collaborative efforts between ophthalmologists, oncologists, and researchers are essential to improve outcomes and quality of life for patients with retinal tumors.
Topics Covered in Retinal Tumors
Retinoblastoma
Capillary Hemangioblastoma
Astrocytic Hamartoma
Vasoproliferative Tumors
Fluorescein Angiography
Laser & Cryotherapy
Related Scientific Sessions at CIOC 2027
Why Attend the Retinal Tumors Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Retinal Tumors work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Retinal Tumors research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Retinal Tumors track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Retinal Tumors Conference 2027 — FAQs
What is the Retinal Tumors track at CIOC 2027?
The Retinal Tumors track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Retinal Tumors. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Retinal Tumors sessions?
Cancer researchers and clinicians, educators and students with an interest in Retinal Tumors are all welcome — whether presenting or attending.
Can I present my research in the Retinal Tumors track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Retinal Tumors sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Retinal Tumors track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.